Harbin Gloria Pharmaceuticals Co (SZSE:002437) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 29, 2025)

View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Harbin Gloria Pharmaceuticals Co's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Harbin Gloria Pharmaceuticals Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Gloria Pharmaceuticals Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harbin Gloria Pharmaceuticals Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Gloria Pharmaceuticals Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Harbin Gloria Pharmaceuticals Co's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Harbin Gloria Pharmaceuticals Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Gloria Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Traded in Other Exchanges

N/A

Address

Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025

Website

http://www.gloria.cc

Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.

Executives

Wang Dong Xu	Director
Guo Yun Pei	Independent director
Wang Yu	Supervisors
Yang Hong Bing	Director
Diao Xiu Qiang	Directors, executives
Liu Yue Yin	Securities Affairs Representative
Guo Lei Feng	Directors, Directors, and Executives
Li Jun Ling	Director
Yang Hai Feng	Executives
Zhang Su Mei	Supervisors
Zhu Ji Man	Director

Harbin Gloria Pharmaceuticals Co Headlines

No Headlines